In this episode of the Diagnosing Health Care Podcast: What has contributed to the biotechnology industry’s explosive growth over the last several years? In this episode, special guests Don and Lisa Drakeman, two former CEOs of biotech companies, reflect on what it takes to succeed, the regulatory challenges they have faced, and how current events are shaping the future of the industry.
Joining our special guests are Epstein Becker Green attorneys Robert Wanerman and Rachel Weisblatt, who address how biotech leaders, entrepreneurs, and investors can best navigate the complex legal issues that arise along the path from product development to thriving business.
For more from today’s special guests, visit: https://www.thebusinessofbiotechnology.com/
The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces. Subscribe on your favorite podcast platform.